Abstract:Metabolic syndrome (MS) is the medical term for the combination of at least three of the following factors: obesity, hyperlipidemia, hyperglycemia, insulin resistance, and hypertension. The spontaneously hypertensive rat (SHR) is an accepted animal model for the study of human MS that reveals all the features of the syndrome when fed high‐fat, high‐carbohydrate diets. The intake of high‐fat diets in rats has been shown to produce brain neuropathology. In humans, MS increases the risk of cognitive impairment, dementia, and Alzheimer's disease. Genistein (GEN) is a phytoestrogen found in soy that lacks feminizing and carcinogenic effects and was found to have neuroprotective and anti‐inflammatory effects in many pathological conditions. Considering that multiple data support that natural phytoestrogens may be therapeutic options for CNS maladies, we aim to elucidate if these properties also apply to a rat model of MS. Thus, GEN effects on neuroinflammation, neurogenesis, and cognition were evaluated in SHR eating a fat/carbohydrate‐enriched diet. To characterize the neuropathology and cognitive dysfunction of MS we fed SHR with a high‐fat diet (4520 kcal/kg) along with a 20% sucrose solution to drink. MS rats displayed a significant increase in body weight, BMI and obesity indexes along with an increased in fasting glucose levels, glucose intolerance, high blood pressure, and high blood triglyceride levels. MS rats were injected with GEN during 2 weeks a dose of 10 mg/kg. We found that MS rats showed a decreased number of DCX+ neural progenitors in the dentate gyrus and treatment with GEN increased this parameter. Expression of GFAP was increased in the DG and CA1 areas of the hippocampus and treatment decreased astrogliosis in all of them. We measured the expression of IBA1+ microglia in the same regions and classified microglia according to their morphology: we found that MS rats presented an increased proportion of the hypertrophied phenotype and GEN produced a shift in microglial phenotypes toward a ramified type. Furthermore, colocalization of IBA1 with the proinflammatory marker TNFα showed increased proportion of proinflammatory microglia in MS and a reduction with GEN treatment. On the other hand, colocalization with the anti‐inflammatory marker Arg1 showed that MS has decreased proportion of anti‐inflammatory microglia and GEN treatment increased this parameter. Cognitive dysfunction was evaluated in rats with MS using a battery of behavioral tests that assessed hippocampus‐dependent spatial and working memory, such as the novel object recognition test (NOR), the novel object location test (NOL), and the free‐movement pattern Y‐maze (FMP‐YMAZE) and the d‐YMAZE. In all of them, MS performed poorly and GEN was able to improve cognitive impairments. These results indicate that GEN was able to exert neuroprotective actions increasing neurogenesis and improving cognitive impairments while decreasing astrogliosis, microgliosis, and neuroinflammatory environment in MS rats. Together, these results open an interesting possibility for proposing this phytoestrogen as a neuroprotective therapy for MS.

IN VITRO ANTI-NEUROINFLAMMATORY EFFECT OF GENISTEIN (4',5,7-TRIHYDROXYISOFLAVONE) ON MICROGLIA HMC3 CELL LINE, AND IN SILICO EVALUATION OF ITS INTERACTION WITH ESTROGEN RECEPTOR-β

G protein-coupled estrogen receptor is involved in the anti-inflammatory effects of genistein in microglia

Inhibitory actions of genistein in human breast cancer (MCF-7) cells

Probing the interactions of genistein with HMGB1 through multi-spectroscopic and in-silico approaches

Genistein: A Review on its Anti-Inflammatory Properties

Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits

[Effect of Genistein on Expression of Angiogenesis Related Factors in HER-2/neu-overexpressing Breast Cancer Cells].

Therapeutic Potential of Genistein: Preclinical Studies, Clinical Evidence, and Nanotechnology Application

Genistein Inhibits the Proliferation of Human HER2-positive Cancer Cells by Downregulating HER2 Receptor

Experimental Study on the Anti inflammatory Effect of Genistein on PC12 Nerve Cells

The phytoestrogen genistein improves hippocampal neurogenesis and cognitive impairment and decreases neuroinflammation in an animal model of metabolic syndrome

Genistein Attenuates Brain Damage Induced by Transient Cerebral Ischemia Through Up-Regulation of ERK Activity in Ovariectomized Mice.

Genistein As an Anti-Inflammatory Agent

Protection by Genistein on Cortical Neurons Against Oxidative Stress Injury Via Inhibition of NF-kappaB, JNK and ERK Signaling Pathway.

Inhibition of Hemolysate-Induced Inos and COX-2 Expression by Genistein Through Suppression of NF-кB Activation in Primary Astrocytes

Effects of Genistein on Hippocampal Neurodegeneration of Ovariectomized Rats

Genistein mitigates oxidative stress and inflammation by regulating Nrf2/HO-1 and NF-κB signaling pathways in hypoxic-ischemic brain damage in neonatal mice

Genistein Attenuates Acute Cerebral Ischemic Damage by Inhibiting the NLRP3 Inflammasome in Reproductively Senescent Mice

EFFECTS OF GENISTEIN ON TUMOR-ASSOCIATED GENE EXPRESSION IN MCF-7 CELLS

Effects of genistein and daidzein on hippocampus neuronal cell proliferation and BDNF expression in H19-7 neural cell line

Genistein as Potential Therapeutic Candidate for Menopausal Symptoms and Other Related Diseases